NO942660L - Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier - Google Patents
Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadierInfo
- Publication number
- NO942660L NO942660L NO942660A NO942660A NO942660L NO 942660 L NO942660 L NO 942660L NO 942660 A NO942660 A NO 942660A NO 942660 A NO942660 A NO 942660A NO 942660 L NO942660 L NO 942660L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- cytolytic
- precursors
- pbmcs
- characteristic
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82393392A | 1992-01-21 | 1992-01-21 | |
PCT/US1993/000083 WO1993014189A1 (en) | 1992-01-21 | 1993-01-07 | Method for determining cytolytic t cell precursors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942660D0 NO942660D0 (no) | 1994-07-15 |
NO942660L true NO942660L (no) | 1994-09-16 |
Family
ID=25240169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942660A NO942660L (no) | 1992-01-21 | 1994-07-15 | Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0624189A4 (fi) |
JP (1) | JPH07503134A (fi) |
KR (1) | KR950700402A (fi) |
AU (1) | AU3435293A (fi) |
CA (1) | CA2128424A1 (fi) |
FI (1) | FI943422A (fi) |
NO (1) | NO942660L (fi) |
WO (1) | WO1993014189A1 (fi) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU664560B2 (en) * | 1991-05-23 | 1995-11-23 | Ludwig Institute For Cancer Research | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
US6280962B1 (en) | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
US6352826B1 (en) | 1991-11-25 | 2002-03-05 | Yoreh Biotechnologies, Ltd. | Method and kit for the detection of retroviral specific antibodies in seronegative individuals |
US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
US5874560A (en) | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
WO1995029193A2 (en) | 1994-04-22 | 1995-11-02 | The Government Of The United States Of America Represented By The Secretary, Department Of Health And Human Services | Melanoma antigens |
US5843648A (en) * | 1995-01-10 | 1998-12-01 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
US7501501B2 (en) | 1995-09-26 | 2009-03-10 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
US6951917B1 (en) | 1995-09-26 | 2005-10-04 | The United States Of America As Represented By The Department Of Health And Human Services | MHC-class II restricted melanoma antigens and their use in therapeutic methods |
AU1394497A (en) * | 1996-01-17 | 1997-08-11 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
US20040156861A1 (en) | 1996-07-11 | 2004-08-12 | Figdor Carl Gustav | Melanoma associated peptide analogues and vaccines against melanoma |
EP0943095A2 (en) * | 1996-11-22 | 1999-09-22 | Shiloov Medical Technologies, Ltd. | A whole blood/mitogen assay for the early detection of a subject with cancer and kit |
-
1993
- 1993-01-07 JP JP5512545A patent/JPH07503134A/ja active Pending
- 1993-01-07 KR KR1019940702508A patent/KR950700402A/ko not_active Application Discontinuation
- 1993-01-07 CA CA002128424A patent/CA2128424A1/en not_active Abandoned
- 1993-01-07 EP EP93902961A patent/EP0624189A4/en not_active Withdrawn
- 1993-01-07 AU AU34352/93A patent/AU3435293A/en not_active Abandoned
- 1993-01-07 WO PCT/US1993/000083 patent/WO1993014189A1/en not_active Application Discontinuation
-
1994
- 1994-07-15 NO NO942660A patent/NO942660L/no unknown
- 1994-07-19 FI FI943422A patent/FI943422A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR950700402A (ko) | 1995-01-16 |
WO1993014189A1 (en) | 1993-07-22 |
EP0624189A4 (en) | 1995-05-17 |
NO942660D0 (no) | 1994-07-15 |
CA2128424A1 (en) | 1993-07-22 |
AU3435293A (en) | 1993-08-03 |
JPH07503134A (ja) | 1995-04-06 |
FI943422A0 (fi) | 1994-07-19 |
FI943422A (fi) | 1994-07-19 |
EP0624189A1 (en) | 1994-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942660L (no) | Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier | |
NO166465C (no) | Fremgangsmaate for bestemmelse av sekvensen av monomerer. | |
DK122184A (da) | Indretning til mikrobiologisk afproevning | |
DK393886A (da) | Monoklone antistoffer og antigen for humane ikke-smaacellede lungecarcinomer | |
FI873398A (fi) | Bestaemning av kliniska parametrar med hjaelp av en enzymatisk immunoprocess. | |
NO932320L (no) | Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne | |
DK199779A (da) | Renset antigen til undersoegelse for neisseria gonorrhoeae antistoffer | |
DE2965570D1 (en) | Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination | |
DK344579A (da) | Diagnostisk middel og fremgangsmaade til paavisning af antimitochondriale eller antinukleaere antistoffer | |
NO961138L (no) | Protein kinase C aktivatorer og anvendelse derav for å redusere ekspresjon av celleantigener | |
NO172910C (no) | Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen | |
FI862242A (fi) | Monoklonala antikroppar foer ej-smaocelliga lungkraeftsvulster hos maenniska. | |
DK412184A (da) | Molekylaert klonet diagnostisk produkt og fremgangsmaade til in vitro detektion af antistof eller antigen | |
ES8706966A1 (es) | Metodo de ensayar muestras de fluido en cuanto a la presencia de anticuerpos contra un microorganismo y dispositivo correspondiente | |
ATE135468T1 (de) | Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen | |
ES2187639T3 (es) | Analisis de fijacion competitiva para antigenos plaquetarios. | |
NO157358C (no) | Antistoffreagens og fremgangsmaate for hurtig bestemmelse av tilstedevaerelse eller fravaer paa roede blodceller av d-antigen. | |
DK98692A (da) | Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof | |
SE7708625L (sv) | Immunanalys for tymopoietin | |
DK112980A (da) | Diagnosefremgangmaade og apparat til gennemfoerelse af fremgangsmaaden | |
SE8603312L (sv) | Sett att overvaka fermentering | |
CA2132868A1 (en) | Method of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells | |
NO931613L (no) | Fremgangsmaate for bestemming av sensiteten og/eller det spesifikke ved et proberingssystem for sporing av antistoffer | |
NO921879L (no) | Fremgangsmaate til maaling av t-celleoverflateantigener i mennesker |